Dr Ivetic graduated from Imperial College London with a BSc (Hons) in 1993 in Biochemistry and additionally became an Associate of the Royal College of Science (ARCS). He then moved to the Marie Curie Research Institute (Oxted, Surrey), where, in association with the Institute of Cancer Research (University of London), he embarked on a PhD in Biochemistry to understand how DNA replication was controlled by the Cell Cycle. His first post-doctoral position was held at the National Institute for Medical Research (which became part of the Francis Crick Institute) where he applied his expertise in protein biochemistry to the field of leukocyte trafficking. He then moved to the Ludwig Institute for Cancer Research (UCL branch, London) for his second postdoctoral position, where he gained extensive knowledge in cell biology, with a main focus on leukocytes and endothelial cells. He subsequently moved to Imperial College London (National Heart and Lung Institute) in July 2005 as part of a Wellcome Trust Research Career Development Award, which enabled him to start his own group in leukocyte trafficking. Work within the Ivetic group is currently investigating molecular mechanisms that regulate leukocyte recruitment in myocardial infarction and other models of sterile injury. He is also interested in the basic biology surrounding endothelial cell permeability.